Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-23

FDA Approved: DALBAVANCIN — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Teva's original ANDA for dalbavancin, allowing generic production of the antibiotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dalbavancin (dalbavancin)

Snippet

ORIG AP for DALBAVANCIN (DALBAVANCIN)